Veterinary Pharmacovigilance Market by Component (Products and Solutions (Integrated and Customized, Standalone) Services (Consulting Services, Support Services, Management Services, Others)) by Deployment Mode (Cloud Based, On Premise) by Application (Veterinary Safety, Veterinary Qualified Person, Clinical Trials, License Agreements and Regulatory Inspections, Risk Management / Risk Minimization Activities, Support in Signal Management Process, Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation, Affiliate Services, Literature, Project Management Services, Others) by Organization Size (Small and Medium Sized Enterprises, Large Enterprises) by End Users (Pharmaceutical Manufacturers, Biotechnology Companies, Medical Research Organizations, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028

Report ID :AMI-797 | Category : Pharmaceuticals | Published Date : February, 2021 | Pages : 402 | Format :PDF

Industry Trends

Global veterinary pharmacovigilance market is expected to grow at a CAGR of 24.9% over the forecast period.

The science and practices involved in the identification, awareness, evaluation and prevention of adverse drug effects or other drug-related concerns are pharmacovigilance. An unintended and unwanted consequence of a medication that arises during its clinical use is an adverse drug reaction (ADR). The increase in diseases among animals has contributed to an increase in the use drugs for animals worldwide. The need for new drug discovery through comprehensive clinical trials has therefore increased. Veterinary Pharmacovigilance is an important aspect in drug research and production procedures. It is expected that the growing occurrence of adverse drug reactions would speed up demand for Veterinary Pharmacovigilance over the forecast period.

The government's attempts to strengthen the monitoring of pharmacovigilance activities have increased. For example, a conference discussing the risk strategies and drug safety involved in veterinary pharmacovigilance was held in 2018. Initiatives like these are expected in the coming years to drive the growth of the market. It is expected that the participation of non-profit organizations to spread awareness will drive the market in the coming years. In addition, in the coming years, regulatory mandates on the conduct of clinical trials and post-marketing vigilance are expected to stimulate demand for veterinary pharmacovigilance services. The European Medicines Agency (EMA) and the U.S. and the Food and Drug Administration (FDA) sets regulatory guidelines during all the stages of clinical trials.

Advances in the creation of ADR databases and information systems have allowed accurate information to be published, which can be further used for prospective studies by research professionals, thus fuelling the overall demand for the veterinary pharmacovigilance market. The main growth factor is the growing occurrence of Adverse Drug Reactions (ADR). ADR puts a major burden on healthcare systems and is one of the leading cause of morbidity in animals in developing as well as developed regions. In addition, in developing countries, leading pharmaceutical firms are concentrating on outsourcing PV services to reduce costs and decrease operating expenses. This is intended to serve as an opportunity to obtain more revenue share by contacting research organizations in developing regions. In an effort to better serve the veterinary sector manufacturers around the world are now focused on remodelling their production processes. During the forecast period, these factors are projected to fuel the demand for veterinary pharmacovigilance market.

In order to build better veterinary pharmacovigilance programs, industry participants are focused on growing R&D activities. Companies are also pursuing tactics to achieve a competitive edge, including new product releases and mergers & acquisitions. In addition, they collaborate with veterinary pharmacovigilance service providers in order to obtain access to patient information and handle workflows. In September 2019, for example, Accenture partnered with Bayer to introduce the INTIENT Clinical framework of the company to simplify and speed up its processes of drug production, thereby expanding its market. In 2017, the company partnered with BioCelebrate to build a platform to aggregate and evaluate clinical knowledge to enhance the efficiency of drug production, thereby improving its R&D capabilities. Such programs help businesses retain their place in the market.

The growing number of ADRs is a major concern in the field of veterinary pharmacovigilance and will lead to a substantial increase in demand for clinical data management services over the forecast period.

Increasing drug usage and drug production patterns, increasing incident rates of adverse drug reactions and drug toxicity, and increasing developments in pharmacovigilance outsourcing are key factors driving the veterinary pharmacovigilance market. With drug use the need for frequent drug monitoring has also increased, ultimately boosting the demand for veterinary pharmacovigilance. The interest of pharmaceutical companies to invest in the R&D activities has increased, to market a new drug to eliminate the effect of adverse drug reactions these companies need pharmacovigilance services. It is anticipated that obstacles to pharmacovigilance automation would impede the growth of the global pharmacovigilance sector. In addition, strict and varied regulatory approval procedures are also expected to restrict the growth of the sector. The safety of newly released and developed drugs in the market is constantly being scrutinized by regulatory bodies. In particular, the U.S. FDA has adopted new rules and regulations to reduce the rising number of adverse drug reactions by amending them. In the global veterinary pharmacovigilance market, major players are focused on the adoption of M&A strategies to increase their market share. For example, in January 2020, Ergomed plc acquired Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc., a specialist pharmacovigilance service provider based in North Carolina.

Component Insights

In component the products and solutions segment dominated the market over the forecast period. The software products adopted by various end users has increased a lot over the years. The need for products and solutions in the pharmaceutical industry is increasing, major drug manufacturers are adopting these solutions in order to check the adverse drug reactions on animals. The adoption of these solutions especially in the developed countries is more as compared to developing countries. The consulting services provided by various end users are aiding in integrating solutions for analysing the performance of the drugs.

Deployment Mode Insights

In deployment the cloud based deployment mode is adopted by most of the end users in the market. The cloud based deployment mode costs less as compared to other modes, also the use of cloud solutions is a pay per as you go service so the cost of these solutions is less as compared to other modes. The information stored on the cloud can be accessed from anywhere which gives an added advantage to the players as they can access vital information.

Application Insights

Veterinary safety is the major application provided by the key players operating in the market. Veterinary safety is important and is the fastest growing segment over the forecast period. The risk management/risk minimization segment will also see a huge growth over the years, the activities related to risk minimization will boost the segment growth.

Organization Size Insights

The large enterprises segment will see a huge growth over the forecast period. The adoption of these products by large organization is more which will boost the segment growth over the forecast period. The use of the solutions in analyzing the adverse drug reactions on animals by major drug manufacturers will aid in boosting the growth of the market. Major pharmaceutical companies are adopting these products in order to analyze the results and effects of the drugs on animals.

End Users Insights

The pharmaceutical manufacturers segment will dominate the market over the forecast period. Pharma companies are investing more on adopting these solutions in order to prevent the effects of drugs on animals indirectly saving costs. The adoption of these products by pharma companies in developed countries is more. Moreover, the use of these solutions is gaining momentum thus increasing the market revenue. The need for veterinary pharmacovigilance products in order to eliminate the adverse drug reactions on animals will increase over the years and adoption of these products by big pharma firms will boost the market revenue over the forecast period.

Regional Insights

The North America region accounts for largest share of the market over the forecast period. The presence of major providers of veterinary pharmacovigilance will boost the growth of these products in this region. Moreover, favourable government policies for the animal safety and security will boost the demand for veterinary pharmacovigilance over the forecast period. The market for veterinary pharmacovigilance will grow significantly in the Asia Pacific region over the years, various regulatory bodies are formed in many countries like India, China, Japan among other to prevent adverse drug reactions on animals thus securing animal safety.

Veterinary Pharmacovigilance Market Revenue & Forecast, (US$ Million), 2020 – 2028

Competitive Landscape

The report provides both, qualitative and quantitative research veterinary pharmacovigilance market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

The major players operating in the market include Accenture, DADA, Delvapv, Demlgroup, Ennov, Excelya, knoell (Cyton Biosciences Ltd.), n8 Collaborate, NORD PHARMA PARTNERS ApS, Oy Medfiles Ltd, Panacea Pharma Projects Limited, Pharsafer Associates Limited, Regultory House, Vet Online Consultancy, ZEINCRO Group, ZIVA Health Consultancy and other market participants.

Veterinary Pharmacovigilance Market:

By Component
- Products and Solutions
- Integrated and Customized
- Standalone
- Services
- Consulting Services
- Support Services
- Management Services
- Others
By Deployment Mode
- Cloud Based
- On Premise
By Application
- Veterinary Safety
- Veterinary Qualified Person
- Clinical Trials
- License Agreements and Regulatory Inspections
- Risk Management / Risk Minimization Activities
- Support in Signal Management Process
- Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation
- Affiliate Services
- Literature
- Project Management Services
- Others
By Organization Size
- Small and Medium Sized Enterprises
- Large Enterprises
- By End Users
- Pharmaceutical Manufacturers
- Biotechnology Companies
- Medical Research Organizations
- Others
By Region:
- North America
  - U.S.
  - Canada
  - Mexico
  - Rest of North America
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
    - Denmark
    - Finland
    - Iceland
    - Sweden
    - Norway
  - Benelux Union
    - Belgium
    - The Netherlands
    - Luxembourg
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - New Zealand
  - Australia
  - South Korea
  - Southeast Asia
    - Indonesia
    - Thailand
    - Malaysia
    - Singapore
    - Rest of Southeast Asia
  - Rest of Asia Pacific
- Middle East & Africa
  - Saudi Arabia
  - UAE
  - Egypt
  - Kuwait
  - South Africa
  - Rest of Middle East & Africa
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2018

1.2.2. Base Year: 2019

1.2.3. Forecast Years: 2020 – 2028

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Veterinary Pharmacovigilance Market

6. Market Synopsis: Veterinary Pharmacovigilance Market

7. Veterinary Pharmacovigilance Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Veterinary Pharmacovigilance Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Veterinary Pharmacovigilance Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Veterinary Pharmacovigilance Market

8. Global Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 – 2028

8.1. Overview

8.1.1. Global Veterinary Pharmacovigilance Market Revenue (US$ Mn)

8.2. Global Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

8.2.1. Products and Solutions (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Integrated and Customized, Standalone)

8.2.1.1. Integrated and Customized

8.2.1.2. Standalone

8.2.2. Services (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Consulting Services, Support Services, Management Services, Others)

8.2.2.1. Consulting Services

8.2.2.2. Support Services

8.2.2.3. Management Services

8.2.2.4. Others

8.3. Key Segment for Channeling Investments

8.3.1. By Component

9. Global Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 – 2028

9.1. Overview

9.2. Global Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

9.2.1. Cloud Based

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 – 2019

9.2.1.3. Market Forecast, 2020 – 2028

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 – 2019

9.2.1.5.1.2. Market Forecast, 2020 – 2028

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 – 2019

9.2.1.5.2.2. Market Forecast, 2020 – 2028

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 – 2019

9.2.1.5.3.2. Market Forecast, 2020 – 2028

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 – 2019

9.2.1.5.4.2. Market Forecast, 2020 – 2028

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 – 2019

9.2.1.5.5.2. Market Forecast, 2020 – 2028

9.2.2. On Premise

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 – 2019

9.2.2.3. Market Forecast, 2020 – 2028

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 – 2019

9.2.2.5.1.2. Market Forecast, 2020 – 2028

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 – 2019

9.2.2.5.2.2. Market Forecast, 2020 – 2028

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 – 2019

9.2.2.5.3.2. Market Forecast, 2020 – 2028

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 – 2019

9.2.2.5.4.2. Market Forecast, 2020 – 2028

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 – 2019

9.2.2.5.5.2. Market Forecast, 2020 – 2028

9.3. Key Segment for Channeling Investments

9.3.1. By Deployment Mode

10. Global Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 – 2028

10.1. Overview

10.2. Global Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

10.2.1. Veterinary Safety

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 – 2019

10.2.1.3. Market Forecast, 2020 – 2028

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 – 2019

10.2.1.5.1.2. Market Forecast, 2020 – 2028

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 – 2019

10.2.1.5.2.2. Market Forecast, 2020 – 2028

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 – 2019

10.2.1.5.3.2. Market Forecast, 2020 – 2028

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 – 2019

10.2.1.5.4.2. Market Forecast, 2020 – 2028

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 – 2019

10.2.1.5.5.2. Market Forecast, 2020 – 2028

10.2.2. Veterinary Qualified Person

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 – 2019

10.2.2.3. Market Forecast, 2020 – 2028

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 – 2019

10.2.2.5.1.2. Market Forecast, 2020 – 2028

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 – 2019

10.2.2.5.2.2. Market Forecast, 2020 – 2028

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 – 2019

10.2.2.5.3.2. Market Forecast, 2020 – 2028

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 – 2019

10.2.2.5.4.2. Market Forecast, 2020 – 2028

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 – 2019

10.2.2.5.5.2. Market Forecast, 2020 – 2028

10.2.3. Clinical Trials

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2015 – 2019

10.2.3.3. Market Forecast, 2020 – 2028

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2015 – 2019

10.2.3.5.1.2. Market Forecast, 2020 – 2028

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2015 – 2019

10.2.3.5.2.2. Market Forecast, 2020 – 2028

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 – 2019

10.2.3.5.3.2. Market Forecast, 2020 – 2028

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 – 2019

10.2.3.5.4.2. Market Forecast, 2020 – 2028

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2015 – 2019

10.2.3.5.5.2. Market Forecast, 2020 – 2028

10.2.4. License Agreements and Regulatory Inspections

10.2.4.1. Definition

10.2.4.2. Market Estimation and Penetration, 2015 – 2019

10.2.4.3. Market Forecast, 2020 – 2028

10.2.4.4. Compound Annual Growth Rate (CAGR)

10.2.4.5. Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1. Market Estimation, 2015 – 2019

10.2.4.5.1.2. Market Forecast, 2020 – 2028

10.2.4.5.2. Europe

10.2.4.5.2.1. Market Estimation, 2015 – 2019

10.2.4.5.2.2. Market Forecast, 2020 – 2028

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1. Market Estimation, 2015 – 2019

10.2.4.5.3.2. Market Forecast, 2020 – 2028

10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1. Market Estimation, 2015 – 2019

10.2.4.5.4.2. Market Forecast, 2020 – 2028

10.2.4.5.5. Latin America

10.2.4.5.5.1. Market Estimation, 2015 – 2019

10.2.4.5.5.2. Market Forecast, 2020 – 2028

10.2.5. Risk Management / Risk Minimization Activities

10.2.5.1. Definition

10.2.5.2. Market Estimation and Penetration, 2015 – 2019

10.2.5.3. Market Forecast, 2020 – 2028

10.2.5.4. Compound Annual Growth Rate (CAGR)

10.2.5.5. Regional Bifurcation

10.2.5.5.1. North America

10.2.5.5.1.1. Market Estimation, 2015 – 2019

10.2.5.5.1.2. Market Forecast, 2020 – 2028

10.2.5.5.2. Europe

10.2.5.5.2.1. Market Estimation, 2015 – 2019

10.2.5.5.2.2. Market Forecast, 2020 – 2028

10.2.5.5.3. Asia Pacific

10.2.5.5.3.1. Market Estimation, 2015 – 2019

10.2.5.5.3.2. Market Forecast, 2020 – 2028

10.2.5.5.4. Middle East and Africa

10.2.5.5.4.1. Market Estimation, 2015 – 2019

10.2.5.5.4.2. Market Forecast, 2020 – 2028

10.2.5.5.5. Latin America

10.2.5.5.5.1. Market Estimation, 2015 – 2019

10.2.5.5.5.2. Market Forecast, 2020 – 2028

10.2.6. Support in Signal Management Process

10.2.6.1. Definition

10.2.6.2. Market Estimation and Penetration, 2015 – 2019

10.2.6.3. Market Forecast, 2020 – 2028

10.2.6.4. Compound Annual Growth Rate (CAGR)

10.2.6.5. Regional Bifurcation

10.2.6.5.1. North America

10.2.6.5.1.1. Market Estimation, 2015 – 2019

10.2.6.5.1.2. Market Forecast, 2020 – 2028

10.2.6.5.2. Europe

10.2.6.5.2.1. Market Estimation, 2015 – 2019

10.2.6.5.2.2. Market Forecast, 2020 – 2028

10.2.6.5.3. Asia Pacific

10.2.6.5.3.1. Market Estimation, 2015 – 2019

10.2.6.5.3.2. Market Forecast, 2020 – 2028

10.2.6.5.4. Middle East and Africa

10.2.6.5.4.1. Market Estimation, 2015 – 2019

10.2.6.5.4.2. Market Forecast, 2020 – 2028

10.2.6.5.5. Latin America

10.2.6.5.5.1. Market Estimation, 2015 – 2019

10.2.6.5.5.2. Market Forecast, 2020 – 2028

10.2.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

10.2.7.1. Definition

10.2.7.2. Market Estimation and Penetration, 2015 – 2019

10.2.7.3. Market Forecast, 2020 – 2028

10.2.7.4. Compound Annual Growth Rate (CAGR)

10.2.7.5. Regional Bifurcation

10.2.7.5.1. North America

10.2.7.5.1.1. Market Estimation, 2015 – 2019

10.2.7.5.1.2. Market Forecast, 2020 – 2028

10.2.7.5.2. Europe

10.2.7.5.2.1. Market Estimation, 2015 – 2019

10.2.7.5.2.2. Market Forecast, 2020 – 2028

10.2.7.5.3. Asia Pacific

10.2.7.5.3.1. Market Estimation, 2015 – 2019

10.2.7.5.3.2. Market Forecast, 2020 – 2028

10.2.7.5.4. Middle East and Africa

10.2.7.5.4.1. Market Estimation, 2015 – 2019

10.2.7.5.4.2. Market Forecast, 2020 – 2028

10.2.7.5.5. Latin America

10.2.7.5.5.1. Market Estimation, 2015 – 2019

10.2.7.5.5.2. Market Forecast, 2020 – 2028

10.2.8. Affiliate Services

10.2.8.1. Definition

10.2.8.2. Market Estimation and Penetration, 2015 – 2019

10.2.8.3. Market Forecast, 2020 – 2028

10.2.8.4. Compound Annual Growth Rate (CAGR)

10.2.8.5. Regional Bifurcation

10.2.8.5.1. North America

10.2.8.5.1.1. Market Estimation, 2015 – 2019

10.2.8.5.1.2. Market Forecast, 2020 – 2028

10.2.8.5.2. Europe

10.2.8.5.2.1. Market Estimation, 2015 – 2019

10.2.8.5.2.2. Market Forecast, 2020 – 2028

10.2.8.5.3. Asia Pacific

10.2.8.5.3.1. Market Estimation, 2015 – 2019

10.2.8.5.3.2. Market Forecast, 2020 – 2028

10.2.8.5.4. Middle East and Africa

10.2.8.5.4.1. Market Estimation, 2015 – 2019

10.2.8.5.4.2. Market Forecast, 2020 – 2028

10.2.8.5.5. Latin America

10.2.8.5.5.1. Market Estimation, 2015 – 2019

10.2.8.5.5.2. Market Forecast, 2020 – 2028

10.2.9. Literature

10.2.9.1. Definition

10.2.9.2. Market Estimation and Penetration, 2015 – 2019

10.2.9.3. Market Forecast, 2020 – 2028

10.2.9.4. Compound Annual Growth Rate (CAGR)

10.2.9.5. Regional Bifurcation

10.2.9.5.1. North America

10.2.9.5.1.1. Market Estimation, 2015 – 2019

10.2.9.5.1.2. Market Forecast, 2020 – 2028

10.2.9.5.2. Europe

10.2.9.5.2.1. Market Estimation, 2015 – 2019

10.2.9.5.2.2. Market Forecast, 2020 – 2028

10.2.9.5.3. Asia Pacific

10.2.9.5.3.1. Market Estimation, 2015 – 2019

10.2.9.5.3.2. Market Forecast, 2020 – 2028

10.2.9.5.4. Middle East and Africa

10.2.9.5.4.1. Market Estimation, 2015 – 2019

10.2.9.5.4.2. Market Forecast, 2020 – 2028

10.2.9.5.5. Latin America

10.2.9.5.5.1. Market Estimation, 2015 – 2019

10.2.9.5.5.2. Market Forecast, 2020 – 2028

10.2.10. Project Management Services

10.2.10.1. Definition

10.2.10.2. Market Estimation and Penetration, 2015 – 2019

10.2.10.3. Market Forecast, 2020 – 2028

10.2.10.4. Compound Annual Growth Rate (CAGR)

10.2.10.5. Regional Bifurcation

10.2.10.5.1. North America

10.2.10.5.1.1. Market Estimation, 2015 – 2019

10.2.10.5.1.2. Market Forecast, 2020 – 2028

10.2.10.5.2. Europe

10.2.10.5.2.1. Market Estimation, 2015 – 2019

10.2.10.5.2.2. Market Forecast, 2020 – 2028

10.2.10.5.3. Asia Pacific

10.2.10.5.3.1. Market Estimation, 2015 – 2019

10.2.10.5.3.2. Market Forecast, 2020 – 2028

10.2.10.5.4. Middle East and Africa

10.2.10.5.4.1. Market Estimation, 2015 – 2019

10.2.10.5.4.2. Market Forecast, 2020 – 2028

10.2.10.5.5. Latin America

10.2.10.5.5.1. Market Estimation, 2015 – 2019

10.2.10.5.5.2. Market Forecast, 2020 – 2028

10.2.11. Others

10.2.11.1. Definition

10.2.11.2. Market Estimation and Penetration, 2015 – 2019

10.2.11.3. Market Forecast, 2020 – 2028

10.2.11.4. Compound Annual Growth Rate (CAGR)

10.2.11.5. Regional Bifurcation

10.2.11.5.1. North America

10.2.11.5.1.1. Market Estimation, 2015 – 2019

10.2.11.5.1.2. Market Forecast, 2020 – 2028

10.2.11.5.2. Europe

10.2.11.5.2.1. Market Estimation, 2015 – 2019

10.2.11.5.2.2. Market Forecast, 2020 – 2028

10.2.11.5.3. Asia Pacific

10.2.11.5.3.1. Market Estimation, 2015 – 2019

10.2.11.5.3.2. Market Forecast, 2020 – 2028

10.2.11.5.4. Middle East and Africa

10.2.11.5.4.1. Market Estimation, 2015 – 2019

10.2.11.5.4.2. Market Forecast, 2020 – 2028

10.2.11.5.5. Latin America

10.2.11.5.5.1. Market Estimation, 2015 – 2019

10.2.11.5.5.2. Market Forecast, 2020 – 2028

10.3. Key Segment for Channeling Investments

10.3.1. By Application

11. Global Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 – 2028

11.1. Overview

11.2. Global Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

11.2.1. Small and Medium Sized Enterprises

11.2.1.1. Definition

11.2.1.2. Market Estimation and Penetration, 2015 – 2019

11.2.1.3. Market Forecast, 2020 – 2028

11.2.1.4. Compound Annual Growth Rate (CAGR)

11.2.1.5. Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2015 – 2019

11.2.1.5.1.2. Market Forecast, 2020 – 2028

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2015 – 2019

11.2.1.5.2.2. Market Forecast, 2020 – 2028

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 – 2019

11.2.1.5.3.2. Market Forecast, 2020 – 2028

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 – 2019

11.2.1.5.4.2. Market Forecast, 2020 – 2028

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2015 – 2019

11.2.1.5.5.2. Market Forecast, 2020 – 2028

11.2.2. Large Enterprises

11.2.2.1. Definition

11.2.2.2. Market Estimation and Penetration, 2015 – 2019

11.2.2.3. Market Forecast, 2020 – 2028

11.2.2.4. Compound Annual Growth Rate (CAGR)

11.2.2.5. Regional Bifurcation

11.2.2.5.1. North America

11.2.2.5.1.1. Market Estimation, 2015 – 2019

11.2.2.5.1.2. Market Forecast, 2020 – 2028

11.2.2.5.2. Europe

11.2.2.5.2.1. Market Estimation, 2015 – 2019

11.2.2.5.2.2. Market Forecast, 2020 – 2028

11.2.2.5.3. Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 – 2019

11.2.2.5.3.2. Market Forecast, 2020 – 2028

11.2.2.5.4. Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 – 2019

11.2.2.5.4.2. Market Forecast, 2020 – 2028

11.2.2.5.5. Latin America

11.2.2.5.5.1. Market Estimation, 2015 – 2019

11.2.2.5.5.2. Market Forecast, 2020 – 2028

11.3. Key Segment for Channeling Investments

11.3.1. By Organization Size

12. Global Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 – 2028

12.1. Overview

12.2. Global Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

12.2.1. Pharmaceutical Manufacturers

12.2.1.1. Definition

12.2.1.2. Market Estimation and Penetration, 2015 – 2019

12.2.1.3. Market Forecast, 2020 – 2028

12.2.1.4. Compound Annual Growth Rate (CAGR)

12.2.1.5. Regional Bifurcation

12.2.1.5.1. North America

12.2.1.5.1.1. Market Estimation, 2015 – 2019

12.2.1.5.1.2. Market Forecast, 2020 – 2028

12.2.1.5.2. Europe

12.2.1.5.2.1. Market Estimation, 2015 – 2019

12.2.1.5.2.2. Market Forecast, 2020 – 2028

12.2.1.5.3. Asia Pacific

12.2.1.5.3.1. Market Estimation, 2015 – 2019

12.2.1.5.3.2. Market Forecast, 2020 – 2028

12.2.1.5.4. Middle East and Africa

12.2.1.5.4.1. Market Estimation, 2015 – 2019

12.2.1.5.4.2. Market Forecast, 2020 – 2028

12.2.1.5.5. Latin America

12.2.1.5.5.1. Market Estimation, 2015 – 2019

12.2.1.5.5.2. Market Forecast, 2020 – 2028

12.2.2. Biotechnology Companies

12.2.2.1. Definition

12.2.2.2. Market Estimation and Penetration, 2015 – 2019

12.2.2.3. Market Forecast, 2020 – 2028

12.2.2.4. Compound Annual Growth Rate (CAGR)

12.2.2.5. Regional Bifurcation

12.2.2.5.1. North America

12.2.2.5.1.1. Market Estimation, 2015 – 2019

12.2.2.5.1.2. Market Forecast, 2020 – 2028

12.2.2.5.2. Europe

12.2.2.5.2.1. Market Estimation, 2015 – 2019

12.2.2.5.2.2. Market Forecast, 2020 – 2028

12.2.2.5.3. Asia Pacific

12.2.2.5.3.1. Market Estimation, 2015 – 2019

12.2.2.5.3.2. Market Forecast, 2020 – 2028

12.2.2.5.4. Middle East and Africa

12.2.2.5.4.1. Market Estimation, 2015 – 2019

12.2.2.5.4.2. Market Forecast, 2020 – 2028

12.2.2.5.5. Latin America

12.2.2.5.5.1. Market Estimation, 2015 – 2019

12.2.2.5.5.2. Market Forecast, 2020 – 2028

12.2.3. Medical Research Organizations

12.2.3.1. Definition

12.2.3.2. Market Estimation and Penetration, 2015 – 2019

12.2.3.3. Market Forecast, 2020 – 2028

12.2.3.4. Compound Annual Growth Rate (CAGR)

12.2.3.5. Regional Bifurcation

12.2.3.5.1. North America

12.2.3.5.1.1. Market Estimation, 2015 – 2019

12.2.3.5.1.2. Market Forecast, 2020 – 2028

12.2.3.5.2. Europe

12.2.3.5.2.1. Market Estimation, 2015 – 2019

12.2.3.5.2.2. Market Forecast, 2020 – 2028

12.2.3.5.3. Asia Pacific

12.2.3.5.3.1. Market Estimation, 2015 – 2019

12.2.3.5.3.2. Market Forecast, 2020 – 2028

12.2.3.5.4. Middle East and Africa

12.2.3.5.4.1. Market Estimation, 2015 – 2019

12.2.3.5.4.2. Market Forecast, 2020 – 2028

12.2.3.5.5. Latin America

12.2.3.5.5.1. Market Estimation, 2015 – 2019

12.2.3.5.5.2. Market Forecast, 2020 – 2028

12.2.4. Others

12.2.4.1. Definition

12.2.4.2. Market Estimation and Penetration, 2015 – 2019

12.2.4.3. Market Forecast, 2020 – 2028

12.2.4.4. Compound Annual Growth Rate (CAGR)

12.2.4.5. Regional Bifurcation

12.2.4.5.1. North America

12.2.4.5.1.1. Market Estimation, 2015 – 2019

12.2.4.5.1.2. Market Forecast, 2020 – 2028

12.2.4.5.2. Europe

12.2.4.5.2.1. Market Estimation, 2015 – 2019

12.2.4.5.2.2. Market Forecast, 2020 – 2028

12.2.4.5.3. Asia Pacific

12.2.4.5.3.1. Market Estimation, 2015 – 2019

12.2.4.5.3.2. Market Forecast, 2020 – 2028

12.2.4.5.4. Middle East and Africa

12.2.4.5.4.1. Market Estimation, 2015 – 2019

12.2.4.5.4.2. Market Forecast, 2020 – 2028

12.2.4.5.5. Latin America

12.2.4.5.5.1. Market Estimation, 2015 – 2019

12.2.4.5.5.2. Market Forecast, 2020 – 2028

12.3. Key Segment for Channeling Investments

12.3.1. By End Users

13. North America Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 - 2028

13.1. Overview

13.1.1. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn)

13.2. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

13.2.1. Products and Solutions

13.2.1.1. Integrated and Customized

13.2.1.2. Standalone

13.2.2. Services

13.2.2.1. Consulting Services

13.2.2.2. Support Services

13.2.2.3. Management Services

13.2.2.4. Others

13.3. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

13.3.1. Cloud Based

13.3.2. On Premise

13.4. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

13.4.1. Veterinary Safety

13.4.2. Veterinary Qualified Person

13.4.3. Clinical Trials

13.4.4. License Agreements and Regulatory Inspections

13.4.5. Risk Management / Risk Minimization Activities

13.4.6. Support in Signal Management Process

13.4.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

13.4.8. Affiliate Services

13.4.9. Literature

13.4.10. Project Management Services

13.4.11. Others

13.5. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.1. Small and Medium Sized Enterprises

13.5.2. Large Enterprises

13.6. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.1. Pharmaceutical Manufacturers

13.6.2. Biotechnology Companies

13.6.3. Medical Research Organizations

13.6.4. Others

13.7. North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

13.7.1. U.S

13.7.1.1. U.S Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

13.7.1.1.1. Products and Solutions

13.7.1.1.1.1. Integrated and Customized

13.7.1.1.1.2. Standalone

13.7.1.1.2. Services

13.7.1.1.2.1. Consulting Services

13.7.1.1.2.2. Support Services

13.7.1.1.2.3. Management Services

13.7.1.1.2.4. Others

13.7.1.2. U.S Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

13.7.1.2.1. Cloud Based

13.7.1.2.2. On Premise

13.7.1.3. U.S Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

13.7.1.3.1. Veterinary Safety

13.7.1.3.2. Veterinary Qualified Person

13.7.1.3.3. Clinical Trials

13.7.1.3.4. License Agreements and Regulatory Inspections

13.7.1.3.5. Risk Management / Risk Minimization Activities

13.7.1.3.6. Support in Signal Management Process

13.7.1.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

13.7.1.3.8. Affiliate Services

13.7.1.3.9. Literature

13.7.1.3.10. Project Management Services

13.7.1.3.11. Others

13.7.1.4. U.S Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.1.4.1. Small and Medium Sized Enterprises

13.7.1.4.2. Large Enterprises

13.7.1.5. U.S Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.1.5.1. Pharmaceutical Manufacturers

13.7.1.5.2. Biotechnology Companies

13.7.1.5.3. Medical Research Organizations

13.7.1.5.4. Others

13.7.2. Canada

13.7.2.1. Canada Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

13.7.2.1.1. Products and Solutions

13.7.2.1.1.1. Integrated and Customized

13.7.2.1.1.2. Standalone

13.7.2.1.2. Services

13.7.2.1.2.1. Consulting Services

13.7.2.1.2.2. Support Services

13.7.2.1.2.3. Management Services

13.7.2.1.2.4. Others

13.7.2.2. Canada Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

13.7.2.2.1. Cloud Based

13.7.2.2.2. On Premise

13.7.2.3. Canada Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

13.7.2.3.1. Veterinary Safety

13.7.2.3.2. Veterinary Qualified Person

13.7.2.3.3. Clinical Trials

13.7.2.3.4. License Agreements and Regulatory Inspections

13.7.2.3.5. Risk Management / Risk Minimization Activities

13.7.2.3.6. Support in Signal Management Process

13.7.2.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

13.7.2.3.8. Affiliate Services

13.7.2.3.9. Literature

13.7.2.3.10. Project Management Services

13.7.2.3.11. Others

13.7.2.4. Canada Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.2.4.1. Small and Medium Sized Enterprises

13.7.2.4.2. Large Enterprises

13.7.2.5. Canada Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.2.5.1. Pharmaceutical Manufacturers

13.7.2.5.2. Biotechnology Companies

13.7.2.5.3. Medical Research Organizations

13.7.2.5.4. Others

13.7.3. Mexico

13.7.3.1. Mexico Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

13.7.3.1.1. Products and Solutions

13.7.3.1.1.1. Integrated and Customized

13.7.3.1.1.2. Standalone

13.7.3.1.2. Services

13.7.3.1.2.1. Consulting Services

13.7.3.1.2.2. Support Services

13.7.3.1.2.3. Management Services

13.7.3.1.2.4. Others

13.7.3.2. Mexico Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

13.7.3.2.1. Cloud Based

13.7.3.2.2. On Premise

13.7.3.3. Mexico Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

13.7.3.3.1. Veterinary Safety

13.7.3.3.2. Veterinary Qualified Person

13.7.3.3.3. Clinical Trials

13.7.3.3.4. License Agreements and Regulatory Inspections

13.7.3.3.5. Risk Management / Risk Minimization Activities

13.7.3.3.6. Support in Signal Management Process

13.7.3.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

13.7.3.3.8. Affiliate Services

13.7.3.3.9. Literature

13.7.3.3.10. Project Management Services

13.7.3.3.11. Others

13.7.3.4. Mexico Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.3.4.1. Small and Medium Sized Enterprises

13.7.3.4.2. Large Enterprises

13.7.3.5. Mexico Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.3.5.1. Pharmaceutical Manufacturers

13.7.3.5.2. Biotechnology Companies

13.7.3.5.3. Medical Research Organizations

13.7.3.5.4. Others

13.7.4. Rest of North America

13.7.4.1. Rest of North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

13.7.4.1.1. Products and Solutions

13.7.4.1.1.1. Integrated and Customized

13.7.4.1.1.2. Standalone

13.7.4.1.2. Services

13.7.4.1.2.1. Consulting Services

13.7.4.1.2.2. Support Services

13.7.4.1.2.3. Management Services

13.7.4.1.2.4. Others

13.7.4.2. Rest of North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

13.7.4.2.1. Cloud Based

13.7.4.2.2. On Premise

13.7.4.3. Rest of North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

13.7.4.3.1. Veterinary Safety

13.7.4.3.2. Veterinary Qualified Person

13.7.4.3.3. Clinical Trials

13.7.4.3.4. License Agreements and Regulatory Inspections

13.7.4.3.5. Risk Management / Risk Minimization Activities

13.7.4.3.6. Support in Signal Management Process

13.7.4.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

13.7.4.3.8. Affiliate Services

13.7.4.3.9. Literature

13.7.4.3.10. Project Management Services

13.7.4.3.11. Others

13.7.4.4. Rest of North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.4.4.1. Small and Medium Sized Enterprises

13.7.4.4.2. Large Enterprises

13.7.4.5. Rest of North America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.4.5.1. Pharmaceutical Manufacturers

13.7.4.5.2. Biotechnology Companies

13.7.4.5.3. Medical Research Organizations

13.7.4.5.4. Others

13.8. Key Segment for Channeling Investments

13.8.1. By Country

13.8.2. By Component

13.8.3. By Deployment Mode

13.8.4. By Application

13.8.5. By Organization Size

13.8.6. By End Users

14. Europe Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 - 2028

14.1. Overview

14.1.1. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn)

14.2. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.2.1. Products and Solutions

14.2.1.1. Integrated and Customized

14.2.1.2. Standalone

14.2.2. Services

14.2.2.1. Consulting Services

14.2.2.2. Support Services

14.2.2.3. Management Services

14.2.2.4. Others

14.3. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.3.1. Cloud Based

14.3.2. On Premise

14.4. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.4.1. Veterinary Safety

14.4.2. Veterinary Qualified Person

14.4.3. Clinical Trials

14.4.4. License Agreements and Regulatory Inspections

14.4.5. Risk Management / Risk Minimization Activities

14.4.6. Support in Signal Management Process

14.4.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.4.8. Affiliate Services

14.4.9. Literature

14.4.10. Project Management Services

14.4.11. Others

14.5. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.5.1. Small and Medium Sized Enterprises

14.5.2. Large Enterprises

14.6. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.1. Pharmaceutical Manufacturers

14.6.2. Biotechnology Companies

14.6.3. Medical Research Organizations

14.6.4. Others

14.7. Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

14.7.1. France

14.7.1.1. France Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.1.1.1. Products and Solutions

14.7.1.1.1.1. Integrated and Customized

14.7.1.1.1.2. Standalone

14.7.1.1.2. Services

14.7.1.1.2.1. Consulting Services

14.7.1.1.2.2. Support Services

14.7.1.1.2.3. Management Services

14.7.1.1.2.4. Others

14.7.1.2. France Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.1.2.1. Cloud Based

14.7.1.2.2. On Premise

14.7.1.3. France Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.1.3.1. Veterinary Safety

14.7.1.3.2. Veterinary Qualified Person

14.7.1.3.3. Clinical Trials

14.7.1.3.4. License Agreements and Regulatory Inspections

14.7.1.3.5. Risk Management / Risk Minimization Activities

14.7.1.3.6. Support in Signal Management Process

14.7.1.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.1.3.8. Affiliate Services

14.7.1.3.9. Literature

14.7.1.3.10. Project Management Services

14.7.1.3.11. Others

14.7.1.4. France Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.1.4.1. Small and Medium Sized Enterprises

14.7.1.4.2. Large Enterprises

14.7.1.5. France Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.1.5.1. Pharmaceutical Manufacturers

14.7.1.5.2. Biotechnology Companies

14.7.1.5.3. Medical Research Organizations

14.7.1.5.4. Others

14.7.2. The UK

14.7.2.1. The UK Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.2.1.1. Products and Solutions

14.7.2.1.1.1. Integrated and Customized

14.7.2.1.1.2. Standalone

14.7.2.1.2. Services

14.7.2.1.2.1. Consulting Services

14.7.2.1.2.2. Support Services

14.7.2.1.2.3. Management Services

14.7.2.1.2.4. Others

14.7.2.2. The UK Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.2.2.1. Cloud Based

14.7.2.2.2. On Premise

14.7.2.3. The UK Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.2.3.1. Veterinary Safety

14.7.2.3.2. Veterinary Qualified Person

14.7.2.3.3. Clinical Trials

14.7.2.3.4. License Agreements and Regulatory Inspections

14.7.2.3.5. Risk Management / Risk Minimization Activities

14.7.2.3.6. Support in Signal Management Process

14.7.2.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.2.3.8. Affiliate Services

14.7.2.3.9. Literature

14.7.2.3.10. Project Management Services

14.7.2.3.11. Others

14.7.2.4. The UK Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.2.4.1. Small and Medium Sized Enterprises

14.7.2.4.2. Large Enterprises

14.7.2.5. The UK Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.2.5.1. Pharmaceutical Manufacturers

14.7.2.5.2. Biotechnology Companies

14.7.2.5.3. Medical Research Organizations

14.7.2.5.4. Others

14.7.3. Spain

14.7.3.1. Spain Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.3.1.1. Products and Solutions

14.7.3.1.1.1. Integrated and Customized

14.7.3.1.1.2. Standalone

14.7.3.1.2. Services

14.7.3.1.2.1. Consulting Services

14.7.3.1.2.2. Support Services

14.7.3.1.2.3. Management Services

14.7.3.1.2.4. Others

14.7.3.2. Spain Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.3.2.1. Cloud Based

14.7.3.2.2. On Premise

14.7.3.3. Spain Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.3.3.1. Veterinary Safety

14.7.3.3.2. Veterinary Qualified Person

14.7.3.3.3. Clinical Trials

14.7.3.3.4. License Agreements and Regulatory Inspections

14.7.3.3.5. Risk Management / Risk Minimization Activities

14.7.3.3.6. Support in Signal Management Process

14.7.3.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.3.3.8. Affiliate Services

14.7.3.3.9. Literature

14.7.3.3.10. Project Management Services

14.7.3.3.11. Others

14.7.3.4. Spain Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.3.4.1. Small and Medium Sized Enterprises

14.7.3.4.2. Large Enterprises

14.7.3.5. Spain Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.3.5.1. Pharmaceutical Manufacturers

14.7.3.5.2. Biotechnology Companies

14.7.3.5.3. Medical Research Organizations

14.7.3.5.4. Others

14.7.4. Germany

14.7.4.1. Germany Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.4.1.1. Products and Solutions

14.7.4.1.1.1. Integrated and Customized

14.7.4.1.1.2. Standalone

14.7.4.1.2. Services

14.7.4.1.2.1. Consulting Services

14.7.4.1.2.2. Support Services

14.7.4.1.2.3. Management Services

14.7.4.1.2.4. Others

14.7.4.2. Germany Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.4.2.1. Cloud Based

14.7.4.2.2. On Premise

14.7.4.3. Germany Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.4.3.1. Veterinary Safety

14.7.4.3.2. Veterinary Qualified Person

14.7.4.3.3. Clinical Trials

14.7.4.3.4. License Agreements and Regulatory Inspections

14.7.4.3.5. Risk Management / Risk Minimization Activities

14.7.4.3.6. Support in Signal Management Process

14.7.4.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.4.3.8. Affiliate Services

14.7.4.3.9. Literature

14.7.4.3.10. Project Management Services

14.7.4.3.11. Others

14.7.4.4. Germany Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.4.4.1. Small and Medium Sized Enterprises

14.7.4.4.2. Large Enterprises

14.7.4.5. Germany Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.4.5.1. Pharmaceutical Manufacturers

14.7.4.5.2. Biotechnology Companies

14.7.4.5.3. Medical Research Organizations

14.7.4.5.4. Others

14.7.5. Italy

14.7.5.1. Italy Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.5.1.1. Products and Solutions

14.7.5.1.1.1. Integrated and Customized

14.7.5.1.1.2. Standalone

14.7.5.1.2. Services

14.7.5.1.2.1. Consulting Services

14.7.5.1.2.2. Support Services

14.7.5.1.2.3. Management Services

14.7.5.1.2.4. Others

14.7.5.2. Italy Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.5.2.1. Cloud Based

14.7.5.2.2. On Premise

14.7.5.3. Italy Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.5.3.1. Veterinary Safety

14.7.5.3.2. Veterinary Qualified Person

14.7.5.3.3. Clinical Trials

14.7.5.3.4. License Agreements and Regulatory Inspections

14.7.5.3.5. Risk Management / Risk Minimization Activities

14.7.5.3.6. Support in Signal Management Process

14.7.5.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.5.3.8. Affiliate Services

14.7.5.3.9. Literature

14.7.5.3.10. Project Management Services

14.7.5.3.11. Others

14.7.5.4. Italy Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.5.4.1. Small and Medium Sized Enterprises

14.7.5.4.2. Large Enterprises

14.7.5.5. Italy Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.5.5.1. Pharmaceutical Manufacturers

14.7.5.5.2. Biotechnology Companies

14.7.5.5.3. Medical Research Organizations

14.7.5.5.4. Others

14.7.6. Nordic Countries

14.7.6.1. Nordic Countries Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.6.1.1. Products and Solutions

14.7.6.1.1.1. Integrated and Customized

14.7.6.1.1.2. Standalone

14.7.6.1.2. Services

14.7.6.1.2.1. Consulting Services

14.7.6.1.2.2. Support Services

14.7.6.1.2.3. Management Services

14.7.6.1.2.4. Others

14.7.6.2. Nordic Countries Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.6.2.1. Cloud Based

14.7.6.2.2. On Premise

14.7.6.3. Nordic Countries Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.6.3.1. Veterinary Safety

14.7.6.3.2. Veterinary Qualified Person

14.7.6.3.3. Clinical Trials

14.7.6.3.4. License Agreements and Regulatory Inspections

14.7.6.3.5. Risk Management / Risk Minimization Activities

14.7.6.3.6. Support in Signal Management Process

14.7.6.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.6.3.8. Affiliate Services

14.7.6.3.9. Literature

14.7.6.3.10. Project Management Services

14.7.6.3.11. Others

14.7.6.4. Nordic Countries Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.6.4.1. Small and Medium Sized Enterprises

14.7.6.4.2. Large Enterprises

14.7.6.5. Nordic Countries Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.6.5.1. Pharmaceutical Manufacturers

14.7.6.5.2. Biotechnology Companies

14.7.6.5.3. Medical Research Organizations

14.7.6.5.4. Others

14.7.6.6. Nordic Countries Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

14.7.6.6.1. Denmark

14.7.6.6.2. Finland

14.7.6.6.3. Iceland

14.7.6.6.4. Sweden

14.7.6.6.5. Norway

14.7.7. Benelux Union

14.7.7.1. Benelux Union Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.7.1.1. Products and Solutions

14.7.7.1.1.1. Integrated and Customized

14.7.7.1.1.2. Standalone

14.7.7.1.2. Services

14.7.7.1.2.1. Consulting Services

14.7.7.1.2.2. Support Services

14.7.7.1.2.3. Management Services

14.7.7.1.2.4. Others

14.7.7.2. Benelux Union Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.7.2.1. Cloud Based

14.7.7.2.2. On Premise

14.7.7.3. Benelux Union Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.7.3.1. Veterinary Safety

14.7.7.3.2. Veterinary Qualified Person

14.7.7.3.3. Clinical Trials

14.7.7.3.4. License Agreements and Regulatory Inspections

14.7.7.3.5. Risk Management / Risk Minimization Activities

14.7.7.3.6. Support in Signal Management Process

14.7.7.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.7.3.8. Affiliate Services

14.7.7.3.9. Literature

14.7.7.3.10. Project Management Services

14.7.7.3.11. Others

14.7.7.4. Benelux Union Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.7.4.1. Small and Medium Sized Enterprises

14.7.7.4.2. Large Enterprises

14.7.7.5. Benelux Union Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.7.5.1. Pharmaceutical Manufacturers

14.7.7.5.2. Biotechnology Companies

14.7.7.5.3. Medical Research Organizations

14.7.7.5.4. Others

14.7.7.6. Benelux Union Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

14.7.7.6.1. Belgium

14.7.7.6.2. The Netherlands

14.7.7.6.3. Luxembourg

14.7.8. Rest of Europe

14.7.8.1. Rest of Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

14.7.8.1.1. Products and Solutions

14.7.8.1.1.1. Integrated and Customized

14.7.8.1.1.2. Standalone

14.7.8.1.2. Services

14.7.8.1.2.1. Consulting Services

14.7.8.1.2.2. Support Services

14.7.8.1.2.3. Management Services

14.7.8.1.2.4. Others

14.7.8.2. Rest of Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

14.7.8.2.1. Cloud Based

14.7.8.2.2. On Premise

14.7.8.3. Rest of Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

14.7.8.3.1. Veterinary Safety

14.7.8.3.2. Veterinary Qualified Person

14.7.8.3.3. Clinical Trials

14.7.8.3.4. License Agreements and Regulatory Inspections

14.7.8.3.5. Risk Management / Risk Minimization Activities

14.7.8.3.6. Support in Signal Management Process

14.7.8.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

14.7.8.3.8. Affiliate Services

14.7.8.3.9. Literature

14.7.8.3.10. Project Management Services

14.7.8.3.11. Others

14.7.8.4. Rest of Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.8.4.1. Small and Medium Sized Enterprises

14.7.8.4.2. Large Enterprises

14.7.8.5. Rest of Europe Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.8.5.1. Pharmaceutical Manufacturers

14.7.8.5.2. Biotechnology Companies

14.7.8.5.3. Medical Research Organizations

14.7.8.5.4. Others

14.8. Key Segment for Channeling Investments

14.8.1. By Country

14.8.2. By Component

14.8.3. By Deployment Mode

14.8.4. By Application

14.8.5. By Organization Size

14.8.6. By End Users

15. Asia Pacific Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 - 2028

15.1. Overview

15.1.1. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn)

15.2. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.2.1. Products and Solutions

15.2.1.1. Integrated and Customized

15.2.1.2. Standalone

15.2.2. Services

15.2.2.1. Consulting Services

15.2.2.2. Support Services

15.2.2.3. Management Services

15.2.2.4. Others

15.3. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.3.1. Cloud Based

15.3.2. On Premise

15.4. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.4.1. Veterinary Safety

15.4.2. Veterinary Qualified Person

15.4.3. Clinical Trials

15.4.4. License Agreements and Regulatory Inspections

15.4.5. Risk Management / Risk Minimization Activities

15.4.6. Support in Signal Management Process

15.4.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.4.8. Affiliate Services

15.4.9. Literature

15.4.10. Project Management Services

15.4.11. Others

15.5. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.5.1. Small and Medium Sized Enterprises

15.5.2. Large Enterprises

15.6. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.1. Pharmaceutical Manufacturers

15.6.2. Biotechnology Companies

15.6.3. Medical Research Organizations

15.6.4. Others

15.7. Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

15.7.1. China

15.7.1.1. China Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.1.1.1. Products and Solutions

15.7.1.1.1.1. Integrated and Customized

15.7.1.1.1.2. Standalone

15.7.1.1.2. Services

15.7.1.1.2.1. Consulting Services

15.7.1.1.2.2. Support Services

15.7.1.1.2.3. Management Services

15.7.1.1.2.4. Others

15.7.1.2. China Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.1.2.1. Cloud Based

15.7.1.2.2. On Premise

15.7.1.3. China Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.1.3.1. Veterinary Safety

15.7.1.3.2. Veterinary Qualified Person

15.7.1.3.3. Clinical Trials

15.7.1.3.4. License Agreements and Regulatory Inspections

15.7.1.3.5. Risk Management / Risk Minimization Activities

15.7.1.3.6. Support in Signal Management Process

15.7.1.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.1.3.8. Affiliate Services

15.7.1.3.9. Literature

15.7.1.3.10. Project Management Services

15.7.1.3.11. Others

15.7.1.4. China Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.1.4.1. Small and Medium Sized Enterprises

15.7.1.4.2. Large Enterprises

15.7.1.5. China Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.1.5.1. Pharmaceutical Manufacturers

15.7.1.5.2. Biotechnology Companies

15.7.1.5.3. Medical Research Organizations

15.7.1.5.4. Others

15.7.2. Japan

15.7.2.1. Japan Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.2.1.1. Products and Solutions

15.7.2.1.1.1. Integrated and Customized

15.7.2.1.1.2. Standalone

15.7.2.1.2. Services

15.7.2.1.2.1. Consulting Services

15.7.2.1.2.2. Support Services

15.7.2.1.2.3. Management Services

15.7.2.1.2.4. Others

15.7.2.2. Japan Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.2.2.1. Cloud Based

15.7.2.2.2. On Premise

15.7.2.3. Japan Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.2.3.1. Veterinary Safety

15.7.2.3.2. Veterinary Qualified Person

15.7.2.3.3. Clinical Trials

15.7.2.3.4. License Agreements and Regulatory Inspections

15.7.2.3.5. Risk Management / Risk Minimization Activities

15.7.2.3.6. Support in Signal Management Process

15.7.2.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.2.3.8. Affiliate Services

15.7.2.3.9. Literature

15.7.2.3.10. Project Management Services

15.7.2.3.11. Others

15.7.2.4. Japan Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.2.4.1. Small and Medium Sized Enterprises

15.7.2.4.2. Large Enterprises

15.7.2.5. Japan Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.2.5.1. Pharmaceutical Manufacturers

15.7.2.5.2. Biotechnology Companies

15.7.2.5.3. Medical Research Organizations

15.7.2.5.4. Others

15.7.3. India

15.7.3.1. India Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.3.1.1. Products and Solutions

15.7.3.1.1.1. Integrated and Customized

15.7.3.1.1.2. Standalone

15.7.3.1.2. Services

15.7.3.1.2.1. Consulting Services

15.7.3.1.2.2. Support Services

15.7.3.1.2.3. Management Services

15.7.3.1.2.4. Others

15.7.3.2. India Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.3.2.1. Cloud Based

15.7.3.2.2. On Premise

15.7.3.3. India Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.3.3.1. Veterinary Safety

15.7.3.3.2. Veterinary Qualified Person

15.7.3.3.3. Clinical Trials

15.7.3.3.4. License Agreements and Regulatory Inspections

15.7.3.3.5. Risk Management / Risk Minimization Activities

15.7.3.3.6. Support in Signal Management Process

15.7.3.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.3.3.8. Affiliate Services

15.7.3.3.9. Literature

15.7.3.3.10. Project Management Services

15.7.3.3.11. Others

15.7.3.4. India Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.3.4.1. Small and Medium Sized Enterprises

15.7.3.4.2. Large Enterprises

15.7.3.5. India Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.3.5.1. Pharmaceutical Manufacturers

15.7.3.5.2. Biotechnology Companies

15.7.3.5.3. Medical Research Organizations

15.7.3.5.4. Others

15.7.4. New Zealand

15.7.4.1. New Zealand Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.4.1.1. Products and Solutions

15.7.4.1.1.1. Integrated and Customized

15.7.4.1.1.2. Standalone

15.7.4.1.2. Services

15.7.4.1.2.1. Consulting Services

15.7.4.1.2.2. Support Services

15.7.4.1.2.3. Management Services

15.7.4.1.2.4. Others

15.7.4.2. New Zealand Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.4.2.1. Cloud Based

15.7.4.2.2. On Premise

15.7.4.3. New Zealand Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.4.3.1. Veterinary Safety

15.7.4.3.2. Veterinary Qualified Person

15.7.4.3.3. Clinical Trials

15.7.4.3.4. License Agreements and Regulatory Inspections

15.7.4.3.5. Risk Management / Risk Minimization Activities

15.7.4.3.6. Support in Signal Management Process

15.7.4.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.4.3.8. Affiliate Services

15.7.4.3.9. Literature

15.7.4.3.10. Project Management Services

15.7.4.3.11. Others

15.7.4.4. New Zealand Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.4.4.1. Small and Medium Sized Enterprises

15.7.4.4.2. Large Enterprises

15.7.4.5. New Zealand Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.4.5.1. Pharmaceutical Manufacturers

15.7.4.5.2. Biotechnology Companies

15.7.4.5.3. Medical Research Organizations

15.7.4.5.4. Others

15.7.5. Australia

15.7.5.1. Australia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.5.1.1. Products and Solutions

15.7.5.1.1.1. Integrated and Customized

15.7.5.1.1.2. Standalone

15.7.5.1.2. Services

15.7.5.1.2.1. Consulting Services

15.7.5.1.2.2. Support Services

15.7.5.1.2.3. Management Services

15.7.5.1.2.4. Others

15.7.5.2. Australia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.5.2.1. Cloud Based

15.7.5.2.2. On Premise

15.7.5.3. Australia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.5.3.1. Veterinary Safety

15.7.5.3.2. Veterinary Qualified Person

15.7.5.3.3. Clinical Trials

15.7.5.3.4. License Agreements and Regulatory Inspections

15.7.5.3.5. Risk Management / Risk Minimization Activities

15.7.5.3.6. Support in Signal Management Process

15.7.5.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.5.3.8. Affiliate Services

15.7.5.3.9. Literature

15.7.5.3.10. Project Management Services

15.7.5.3.11. Others

15.7.5.4. Australia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.5.4.1. Small and Medium Sized Enterprises

15.7.5.4.2. Large Enterprises

15.7.5.5. Australia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.5.5.1. Pharmaceutical Manufacturers

15.7.5.5.2. Biotechnology Companies

15.7.5.5.3. Medical Research Organizations

15.7.5.5.4. Others

15.7.6. South Korea

15.7.6.1. South Korea Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.6.1.1. Products and Solutions

15.7.6.1.1.1. Integrated and Customized

15.7.6.1.1.2. Standalone

15.7.6.1.2. Services

15.7.6.1.2.1. Consulting Services

15.7.6.1.2.2. Support Services

15.7.6.1.2.3. Management Services

15.7.6.1.2.4. Others

15.7.6.2. South Korea Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.6.2.1. Cloud Based

15.7.6.2.2. On Premise

15.7.6.3. South Korea Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.6.3.1. Veterinary Safety

15.7.6.3.2. Veterinary Qualified Person

15.7.6.3.3. Clinical Trials

15.7.6.3.4. License Agreements and Regulatory Inspections

15.7.6.3.5. Risk Management / Risk Minimization Activities

15.7.6.3.6. Support in Signal Management Process

15.7.6.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.6.3.8. Affiliate Services

15.7.6.3.9. Literature

15.7.6.3.10. Project Management Services

15.7.6.3.11. Others

15.7.6.4. South Korea Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.6.4.1. Small and Medium Sized Enterprises

15.7.6.4.2. Large Enterprises

15.7.6.5. South Korea Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.6.5.1. Pharmaceutical Manufacturers

15.7.6.5.2. Biotechnology Companies

15.7.6.5.3. Medical Research Organizations

15.7.6.5.4. Others

15.7.7. Southeast Asia

15.7.7.1. Southeast Asia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.7.1.1. Products and Solutions

15.7.7.1.1.1. Integrated and Customized

15.7.7.1.1.2. Standalone

15.7.7.1.2. Services

15.7.7.1.2.1. Consulting Services

15.7.7.1.2.2. Support Services

15.7.7.1.2.3. Management Services

15.7.7.1.2.4. Others

15.7.7.2. Southeast Asia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.7.2.1. Cloud Based

15.7.7.2.2. On Premise

15.7.7.3. Southeast Asia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.7.3.1. Veterinary Safety

15.7.7.3.2. Veterinary Qualified Person

15.7.7.3.3. Clinical Trials

15.7.7.3.4. License Agreements and Regulatory Inspections

15.7.7.3.5. Risk Management / Risk Minimization Activities

15.7.7.3.6. Support in Signal Management Process

15.7.7.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.7.3.8. Affiliate Services

15.7.7.3.9. Literature

15.7.7.3.10. Project Management Services

15.7.7.3.11. Others

15.7.7.4. Southeast Asia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.7.4.1. Small and Medium Sized Enterprises

15.7.7.4.2. Large Enterprises

15.7.7.5. Southeast Asia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.7.5.1. Pharmaceutical Manufacturers

15.7.7.5.2. Biotechnology Companies

15.7.7.5.3. Medical Research Organizations

15.7.7.5.4. Others

15.7.7.6. Southeast Asia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

15.7.7.6.1. Indonesia

15.7.7.6.2. Thailand

15.7.7.6.3. Malaysia

15.7.7.6.4. Singapore

15.7.7.6.5. Rest of Southeast Asia

15.7.8. Rest of Asia Pacific

15.7.8.1. Rest of Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

15.7.8.1.1. Products and Solutions

15.7.8.1.1.1. Integrated and Customized

15.7.8.1.1.2. Standalone

15.7.8.1.2. Services

15.7.8.1.2.1. Consulting Services

15.7.8.1.2.2. Support Services

15.7.8.1.2.3. Management Services

15.7.8.1.2.4. Others

15.7.8.2. Rest of Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

15.7.8.2.1. Cloud Based

15.7.8.2.2. On Premise

15.7.8.3. Rest of Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

15.7.8.3.1. Veterinary Safety

15.7.8.3.2. Veterinary Qualified Person

15.7.8.3.3. Clinical Trials

15.7.8.3.4. License Agreements and Regulatory Inspections

15.7.8.3.5. Risk Management / Risk Minimization Activities

15.7.8.3.6. Support in Signal Management Process

15.7.8.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

15.7.8.3.8. Affiliate Services

15.7.8.3.9. Literature

15.7.8.3.10. Project Management Services

15.7.8.3.11. Others

15.7.8.4. Rest of Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.8.4.1. Small and Medium Sized Enterprises

15.7.8.4.2. Large Enterprises

15.7.8.5. Rest of Asia Pacific Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.8.5.1. Pharmaceutical Manufacturers

15.7.8.5.2. Biotechnology Companies

15.7.8.5.3. Medical Research Organizations

15.7.8.5.4. Others

15.8. Key Segment for Channeling Investments

15.8.1. By Country

15.8.2. By Component

15.8.3. By Deployment Mode

15.8.4. By Application

15.8.5. By Organization Size

15.8.6. By End Users

16. Middle East and Africa Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 - 2028

16.1. Overview

16.1.1. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn)

16.2. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.2.1. Products and Solutions

16.2.1.1. Integrated and Customized

16.2.1.2. Standalone

16.2.2. Services

16.2.2.1. Consulting Services

16.2.2.2. Support Services

16.2.2.3. Management Services

16.2.2.4. Others

16.3. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.3.1. Cloud Based

16.3.2. On Premise

16.4. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.4.1. Veterinary Safety

16.4.2. Veterinary Qualified Person

16.4.3. Clinical Trials

16.4.4. License Agreements and Regulatory Inspections

16.4.5. Risk Management / Risk Minimization Activities

16.4.6. Support in Signal Management Process

16.4.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.4.8. Affiliate Services

16.4.9. Literature

16.4.10. Project Management Services

16.4.11. Others

16.5. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.5.1. Small and Medium Sized Enterprises

16.5.2. Large Enterprises

16.6. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.1. Pharmaceutical Manufacturers

16.6.2. Biotechnology Companies

16.6.3. Medical Research Organizations

16.6.4. Others

16.7. Middle East and Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

16.7.1. Saudi Arabia

16.7.1.1. Saudi Arabia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.7.1.1.1. Products and Solutions

16.7.1.1.1.1. Integrated and Customized

16.7.1.1.1.2. Standalone

16.7.1.1.2. Services

16.7.1.1.2.1. Consulting Services

16.7.1.1.2.2. Support Services

16.7.1.1.2.3. Management Services

16.7.1.1.2.4. Others

16.7.1.2. Saudi Arabia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.7.1.2.1. Cloud Based

16.7.1.2.2. On Premise

16.7.1.3. Saudi Arabia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.7.1.3.1. Veterinary Safety

16.7.1.3.2. Veterinary Qualified Person

16.7.1.3.3. Clinical Trials

16.7.1.3.4. License Agreements and Regulatory Inspections

16.7.1.3.5. Risk Management / Risk Minimization Activities

16.7.1.3.6. Support in Signal Management Process

16.7.1.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.7.1.3.8. Affiliate Services

16.7.1.3.9. Literature

16.7.1.3.10. Project Management Services

16.7.1.3.11. Others

16.7.1.4. Saudi Arabia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.1.4.1. Small and Medium Sized Enterprises

16.7.1.4.2. Large Enterprises

16.7.1.5. Saudi Arabia Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.1.5.1. Pharmaceutical Manufacturers

16.7.1.5.2. Biotechnology Companies

16.7.1.5.3. Medical Research Organizations

16.7.1.5.4. Others

16.7.2. UAE

16.7.2.1. UAE Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.7.2.1.1. Products and Solutions

16.7.2.1.1.1. Integrated and Customized

16.7.2.1.1.2. Standalone

16.7.2.1.2. Services

16.7.2.1.2.1. Consulting Services

16.7.2.1.2.2. Support Services

16.7.2.1.2.3. Management Services

16.7.2.1.2.4. Others

16.7.2.2. UAE Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.7.2.2.1. Cloud Based

16.7.2.2.2. On Premise

16.7.2.3. UAE Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.7.2.3.1. Veterinary Safety

16.7.2.3.2. Veterinary Qualified Person

16.7.2.3.3. Clinical Trials

16.7.2.3.4. License Agreements and Regulatory Inspections

16.7.2.3.5. Risk Management / Risk Minimization Activities

16.7.2.3.6. Support in Signal Management Process

16.7.2.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.7.2.3.8. Affiliate Services

16.7.2.3.9. Literature

16.7.2.3.10. Project Management Services

16.7.2.3.11. Others

16.7.2.4. UAE Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.2.4.1. Small and Medium Sized Enterprises

16.7.2.4.2. Large Enterprises

16.7.2.5. UAE Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.2.5.1. Pharmaceutical Manufacturers

16.7.2.5.2. Biotechnology Companies

16.7.2.5.3. Medical Research Organizations

16.7.2.5.4. Others

16.7.3. Egypt

16.7.3.1. Egypt Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.7.3.1.1. Products and Solutions

16.7.3.1.1.1. Integrated and Customized

16.7.3.1.1.2. Standalone

16.7.3.1.2. Services

16.7.3.1.2.1. Consulting Services

16.7.3.1.2.2. Support Services

16.7.3.1.2.3. Management Services

16.7.3.1.2.4. Others

16.7.3.2. Egypt Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.7.3.2.1. Cloud Based

16.7.3.2.2. On Premise

16.7.3.3. Egypt Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.7.3.3.1. Veterinary Safety

16.7.3.3.2. Veterinary Qualified Person

16.7.3.3.3. Clinical Trials

16.7.3.3.4. License Agreements and Regulatory Inspections

16.7.3.3.5. Risk Management / Risk Minimization Activities

16.7.3.3.6. Support in Signal Management Process

16.7.3.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.7.3.3.8. Affiliate Services

16.7.3.3.9. Literature

16.7.3.3.10. Project Management Services

16.7.3.3.11. Others

16.7.3.4. Egypt Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.3.4.1. Small and Medium Sized Enterprises

16.7.3.4.2. Large Enterprises

16.7.3.5. Egypt Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.3.5.1. Pharmaceutical Manufacturers

16.7.3.5.2. Biotechnology Companies

16.7.3.5.3. Medical Research Organizations

16.7.3.5.4. Others

16.7.4. Kuwait

16.7.4.1. Kuwait Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.7.4.1.1. Products and Solutions

16.7.4.1.1.1. Integrated and Customized

16.7.4.1.1.2. Standalone

16.7.4.1.2. Services

16.7.4.1.2.1. Consulting Services

16.7.4.1.2.2. Support Services

16.7.4.1.2.3. Management Services

16.7.4.1.2.4. Others

16.7.4.2. Kuwait Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.7.4.2.1. Cloud Based

16.7.4.2.2. On Premise

16.7.4.3. Kuwait Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.7.4.3.1. Veterinary Safety

16.7.4.3.2. Veterinary Qualified Person

16.7.4.3.3. Clinical Trials

16.7.4.3.4. License Agreements and Regulatory Inspections

16.7.4.3.5. Risk Management / Risk Minimization Activities

16.7.4.3.6. Support in Signal Management Process

16.7.4.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.7.4.3.8. Affiliate Services

16.7.4.3.9. Literature

16.7.4.3.10. Project Management Services

16.7.4.3.11. Others

16.7.4.4. Kuwait Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.4.4.1. Small and Medium Sized Enterprises

16.7.4.4.2. Large Enterprises

16.7.4.5. Kuwait Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.4.5.1. Pharmaceutical Manufacturers

16.7.4.5.2. Biotechnology Companies

16.7.4.5.3. Medical Research Organizations

16.7.4.5.4. Others

16.7.5. South Africa

16.7.5.1. South Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.7.5.1.1. Products and Solutions

16.7.5.1.1.1. Integrated and Customized

16.7.5.1.1.2. Standalone

16.7.5.1.2. Services

16.7.5.1.2.1. Consulting Services

16.7.5.1.2.2. Support Services

16.7.5.1.2.3. Management Services

16.7.5.1.2.4. Others

16.7.5.2. South Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.7.5.2.1. Cloud Based

16.7.5.2.2. On Premise

16.7.5.3. South Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.7.5.3.1. Veterinary Safety

16.7.5.3.2. Veterinary Qualified Person

16.7.5.3.3. Clinical Trials

16.7.5.3.4. License Agreements and Regulatory Inspections

16.7.5.3.5. Risk Management / Risk Minimization Activities

16.7.5.3.6. Support in Signal Management Process

16.7.5.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.7.5.3.8. Affiliate Services

16.7.5.3.9. Literature

16.7.5.3.10. Project Management Services

16.7.5.3.11. Others

16.7.5.4. South Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.5.4.1. Small and Medium Sized Enterprises

16.7.5.4.2. Large Enterprises

16.7.5.5. South Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.5.5.1. Pharmaceutical Manufacturers

16.7.5.5.2. Biotechnology Companies

16.7.5.5.3. Medical Research Organizations

16.7.5.5.4. Others

16.7.6. Rest of Middle East & Africa

16.7.6.1. Rest of Middle East & Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

16.7.6.1.1. Products and Solutions

16.7.6.1.1.1. Integrated and Customized

16.7.6.1.1.2. Standalone

16.7.6.1.2. Services

16.7.6.1.2.1. Consulting Services

16.7.6.1.2.2. Support Services

16.7.6.1.2.3. Management Services

16.7.6.1.2.4. Others

16.7.6.2. Rest of Middle East & Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

16.7.6.2.1. Cloud Based

16.7.6.2.2. On Premise

16.7.6.3. Rest of Middle East & Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

16.7.6.3.1. Veterinary Safety

16.7.6.3.2. Veterinary Qualified Person

16.7.6.3.3. Clinical Trials

16.7.6.3.4. License Agreements and Regulatory Inspections

16.7.6.3.5. Risk Management / Risk Minimization Activities

16.7.6.3.6. Support in Signal Management Process

16.7.6.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

16.7.6.3.8. Affiliate Services

16.7.6.3.9. Literature

16.7.6.3.10. Project Management Services

16.7.6.3.11. Others

16.7.6.4. Rest of Middle East & Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.6.4.1. Small and Medium Sized Enterprises

16.7.6.4.2. Large Enterprises

16.7.6.5. Rest of Middle East & Africa Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.6.5.1. Pharmaceutical Manufacturers

16.7.6.5.2. Biotechnology Companies

16.7.6.5.3. Medical Research Organizations

16.7.6.5.4. Others

16.8. Key Segment for Channeling Investments

16.8.1. By Country

16.8.2. By Component

16.8.3. By Deployment Mode

16.8.4. By Application

16.8.5. By Organization Size

16.8.6. By End Users

17. Latin America Veterinary Pharmacovigilance Market Analysis and Forecasts, 2020 - 2028

17.1. Overview

17.1.1. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn)

17.2. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

17.2.1. Products and Solutions

17.2.1.1. Integrated and Customized

17.2.1.2. Standalone

17.2.2. Services

17.2.2.1. Consulting Services

17.2.2.2. Support Services

17.2.2.3. Management Services

17.2.2.4. Others

17.3. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

17.3.1. Cloud Based

17.3.2. On Premise

17.4. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

17.4.1. Veterinary Safety

17.4.2. Veterinary Qualified Person

17.4.3. Clinical Trials

17.4.4. License Agreements and Regulatory Inspections

17.4.5. Risk Management / Risk Minimization Activities

17.4.6. Support in Signal Management Process

17.4.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

17.4.8. Affiliate Services

17.4.9. Literature

17.4.10. Project Management Services

17.4.11. Others

17.5. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.5.1. Small and Medium Sized Enterprises

17.5.2. Large Enterprises

17.6. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

17.6.1. Pharmaceutical Manufacturers

17.6.2. Biotechnology Companies

17.6.3. Medical Research Organizations

17.6.4. Others

17.7. Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Country

17.7.1. Brazil

17.7.1.1. Brazil Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

17.7.1.1.1. Products and Solutions

17.7.1.1.1.1. Integrated and Customized

17.7.1.1.1.2. Standalone

17.7.1.1.2. Services

17.7.1.1.2.1. Consulting Services

17.7.1.1.2.2. Support Services

17.7.1.1.2.3. Management Services

17.7.1.1.2.4. Others

17.7.1.2. Brazil Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

17.7.1.2.1. Cloud Based

17.7.1.2.2. On Premise

17.7.1.3. Brazil Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

17.7.1.3.1. Veterinary Safety

17.7.1.3.2. Veterinary Qualified Person

17.7.1.3.3. Clinical Trials

17.7.1.3.4. License Agreements and Regulatory Inspections

17.7.1.3.5. Risk Management / Risk Minimization Activities

17.7.1.3.6. Support in Signal Management Process

17.7.1.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

17.7.1.3.8. Affiliate Services

17.7.1.3.9. Literature

17.7.1.3.10. Project Management Services

17.7.1.3.11. Others

17.7.1.4. Brazil Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.7.1.4.1. Small and Medium Sized Enterprises

17.7.1.4.2. Large Enterprises

17.7.1.5. Brazil Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

17.7.1.5.1. Pharmaceutical Manufacturers

17.7.1.5.2. Biotechnology Companies

17.7.1.5.3. Medical Research Organizations

17.7.1.5.4. Others

17.7.2. Argentina

17.7.2.1. Argentina Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

17.7.2.1.1. Products and Solutions

17.7.2.1.1.1. Integrated and Customized

17.7.2.1.1.2. Standalone

17.7.2.1.2. Services

17.7.2.1.2.1. Consulting Services

17.7.2.1.2.2. Support Services

17.7.2.1.2.3. Management Services

17.7.2.1.2.4. Others

17.7.2.2. Argentina Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

17.7.2.2.1. Cloud Based

17.7.2.2.2. On Premise

17.7.2.3. Argentina Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

17.7.2.3.1. Veterinary Safety

17.7.2.3.2. Veterinary Qualified Person

17.7.2.3.3. Clinical Trials

17.7.2.3.4. License Agreements and Regulatory Inspections

17.7.2.3.5. Risk Management / Risk Minimization Activities

17.7.2.3.6. Support in Signal Management Process

17.7.2.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

17.7.2.3.8. Affiliate Services

17.7.2.3.9. Literature

17.7.2.3.10. Project Management Services

17.7.2.3.11. Others

17.7.2.4. Argentina Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.7.2.4.1. Small and Medium Sized Enterprises

17.7.2.4.2. Large Enterprises

17.7.2.5. Argentina Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

17.7.2.5.1. Pharmaceutical Manufacturers

17.7.2.5.2. Biotechnology Companies

17.7.2.5.3. Medical Research Organizations

17.7.2.5.4. Others

17.7.3. Rest of Latin America

17.7.3.1. Rest of Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Component

17.7.3.1.1. Products and Solutions

17.7.3.1.1.1. Integrated and Customized

17.7.3.1.1.2. Standalone

17.7.3.1.2. Services

17.7.3.1.2.1. Consulting Services

17.7.3.1.2.2. Support Services

17.7.3.1.2.3. Management Services

17.7.3.1.2.4. Others

17.7.3.2. Rest of Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Deployment Mode

17.7.3.2.1. Cloud Based

17.7.3.2.2. On Premise

17.7.3.3. Rest of Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Application

17.7.3.3.1. Veterinary Safety

17.7.3.3.2. Veterinary Qualified Person

17.7.3.3.3. Clinical Trials

17.7.3.3.4. License Agreements and Regulatory Inspections

17.7.3.3.5. Risk Management / Risk Minimization Activities

17.7.3.3.6. Support in Signal Management Process

17.7.3.3.7. Translations of Adverse Reaction Reports and Other Pharmacovigilance Documentation

17.7.3.3.8. Affiliate Services

17.7.3.3.9. Literature

17.7.3.3.10. Project Management Services

17.7.3.3.11. Others

17.7.3.4. Rest of Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.7.3.4.1. Small and Medium Sized Enterprises

17.7.3.4.2. Large Enterprises

17.7.3.5. Rest of Latin America Veterinary Pharmacovigilance Market Revenue (US$ Mn) and Forecasts, By End Users

17.7.3.5.1. Pharmaceutical Manufacturers

17.7.3.5.2. Biotechnology Companies

17.7.3.5.3. Medical Research Organizations

17.7.3.5.4. Others

17.8. Key Segment for Channeling Investments

17.8.1. By Country

17.8.2. By Component

17.8.3. By Deployment Mode

17.8.4. By Application

17.8.5. By Organization Size

17.8.6. By End Users

18. Competitive Benchmarking

18.1. Market Share Analysis, 2019

18.2. Global Presence and Growth Strategies

18.2.1. Mergers and Acquisitions

18.2.2. Product Launches

18.2.3. Investments Trends

18.2.4. R&D Initiatives

19. Player Profiles

19.1. Accenture

19.1.1. Company Details

19.1.2. Company Overview

19.1.3. Product Offerings

19.1.4. Key Developments

19.1.5. Financial Analysis

19.1.6. SWOT Analysis

19.1.7. Business Strategies

19.2. DADA

19.2.1. Company Details

19.2.2. Company Overview

19.2.3. Product Offerings

19.2.4. Key Developments

19.2.5. Financial Analysis

19.2.6. SWOT Analysis

19.2.7. Business Strategies

19.3. Delvapv

19.3.1. Company Details

19.3.2. Company Overview

19.3.3. Product Offerings

19.3.4. Key Developments

19.3.5. Financial Analysis

19.3.6. SWOT Analysis

19.3.7. Business Strategies

19.4. Demlgroup

19.4.1. Company Details

19.4.2. Company Overview

19.4.3. Product Offerings

19.4.4. Key Developments

19.4.5. Financial Analysis

19.4.6. SWOT Analysis

19.4.7. Business Strategies

19.5. Ennov

19.5.1. Company Details

19.5.2. Company Overview

19.5.3. Product Offerings

19.5.4. Key Developments

19.5.5. Financial Analysis

19.5.6. SWOT Analysis

19.5.7. Business Strategies

19.6. Excelya

19.6.1. Company Details

19.6.2. Company Overview

19.6.3. Product Offerings

19.6.4. Key Developments

19.6.5. Financial Analysis

19.6.6. SWOT Analysis

19.6.7. Business Strategies

19.7. knoell (Cyton Biosciences Ltd.)

19.7.1. Company Details

19.7.2. Company Overview

19.7.3. Product Offerings

19.7.4. Key Developments

19.7.5. Financial Analysis

19.7.6. SWOT Analysis

19.7.7. Business Strategies

19.8. n8 Collaborate

19.8.1. Company Details

19.8.2. Company Overview

19.8.3. Product Offerings

19.8.4. Key Developments

19.8.5. Financial Analysis

19.8.6. SWOT Analysis

19.8.7. Business Strategies

19.9. NORD PHARMA PARTNERS ApS

19.9.1. Company Details

19.9.2. Company Overview

19.9.3. Product Offerings

19.9.4. Key Developments

19.9.5. Financial Analysis

19.9.6. SWOT Analysis

19.9.7. Business Strategies

19.10. Oy Medfiles Ltd

19.10.1. Company Details

19.10.2. Company Overview

19.10.3. Product Offerings

19.10.4. Key Developments

19.10.5. Financial Analysis

19.10.6. SWOT Analysis

19.10.7. Business Strategies

19.11. Panacea Pharma Projects Limited

19.11.1. Company Details

19.11.2. Company Overview

19.11.3. Product Offerings

19.11.4. Key Developments

19.11.5. Financial Analysis

19.11.6. SWOT Analysis

19.11.7. Business Strategies

19.12. Pharsafer Associates Limited

19.12.1. Company Details

19.12.2. Company Overview

19.12.3. Product Offerings

19.12.4. Key Developments

19.12.5. Financial Analysis

19.12.6. SWOT Analysis

19.12.7. Business Strategies

19.13. Regultory House

19.13.1. Company Details

19.13.2. Company Overview

19.13.3. Product Offerings

19.13.4. Key Developments

19.13.5. Financial Analysis

19.13.6. SWOT Analysis

19.13.7. Business Strategies

19.14. Vet Online Consultancy

19.14.1. Company Details

19.14.2. Company Overview

19.14.3. Product Offerings

19.14.4. Key Developments

19.14.5. Financial Analysis

19.14.6. SWOT Analysis

19.14.7. Business Strategies

19.15. ZEINCRO Group

19.15.1. Company Details

19.15.2. Company Overview

19.15.3. Product Offerings

19.15.4. Key Developments

19.15.5. Financial Analysis

19.15.6. SWOT Analysis

19.15.7. Business Strategies

19.16. ZIVA Health Consultancy

19.16.1. Company Details

19.16.2. Company Overview

19.16.3. Product Offerings

19.16.4. Key Developments

19.16.5. Financial Analysis

19.16.6. SWOT Analysis

19.16.7. Business Strategies

19.17. Other Industry Participants

20. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $4600

Multi users $8200

Global users $9100

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com